Long-term Clinical Outcomes of Combined ‘en Bloc’ Liver and Pancreas Transplantation in 19 Patients with End-Stage Liver Disease and Diabetes Mellitus

何晓顺,陈知水,鞠卫强,林建伟,朱晓峰,王东平,马毅,巫林伟,邰强

DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2014.11.002

2014-01-01

Abstract:Objective To investigate the clinical efficacy of combined en-bloc liver-pancreas transplantation in patients with end-stage liver disease and diabetes mellitus.Method The clinical data of 19 cases of combined en-bloc liver-pancreas transplantation were retrospectively analyzed.The primary diseases of 19 cases included 9 cases of liver cirrhosis after hepatitis B,7 cases of hepatocellular carcinoma,and cholangiocellular carcinoma,and alcoholic cirrhosis of the liver and biliary complications after liver transplantation in 1 case each.All patients were rendered dependent from insulin therapy (62.3 ± 26.8 U/day) before transplantation,and duration of diabetes mellitus was (4.0 ± 3.6) years.Mean levels of glycosylated hemoglobin and C-peptide in all recipients were (7.9 ± 1.7)％ and (0.68 ± 0.40) nmol/L before transplantation.The pancreas and the whole digestive tract of the recipients were reserved.The liver and pancreas duodenal organ cluster grafts were implanted after the resection of the diseased liver.The liver and kidney function,blood glucose,C-peptide,infection,rejection,vascular complications,biliary complications and other indicators were monitored postoperatively.Result Median posttransplant follow-up was currently 25.8 ± 25.4 months (1 to 96 months).From two weeks after operations,no insulin was used in 18 patients,and the blood glucose levels returned to almost normal.Mean glycosylated hemoglobin values decreased from pretransplant (7.9 ± 1.7)％ to (5.0 ± 0.3)％ 3 months posttransplantation (P＜0.05).Mean C-peptide values increased from pretransplant 0.68 ± 0.40 nmol/L to 1.20 ± 0.78 nmol/L 3 months posttransplantation (P ＜ 0.05).There was only one recipient (5.3 ％) who remained exogenous insulin (24 U/day) dependence 45 days posttransplantation.Alanine aminotransferase (ALT),aspartate aminotransferase (AST) and total bilirubin became normal after one week.So far of the followed up,there was no bilary complication.Among the 19 patients,only three recipients died.One died of graft-versus-host disease at first month after operation,one died of acute monocytic leukemia at 12.5 months after operation,and one died of digestive tract perforation and peritonitis at 26 months after operation.Conclusion Our results indicate that combined en-bloc liver-pancreas transplantation is technically feasible and leads to excellent long-term control of glucose metabolism in patients with end-stage liver disease and diabetes mellitus.